Skip to main content

DFW molecular diagnostic company rolls out four-in-one COVID test

An early pivot to focus much of its efforts on the COVID-19 has allowed GeneIQ to rapidly grow, as well as launch a number of efforts aimed at stopping the virus' spread. And its most recently, the company has rolled out a new test that can detect the flu, the common cold and COVID-19.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.